Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-035585

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 24, 2017
Accepted (ET)
May 25, 2017 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF1,F2May 24, 2017S509$47.27D91,206D
Common stockF1,F2,F3May 24, 2017S509$47.27D91,246ISee footnote
Common stockF1,F4May 25, 2017S509$46.92D90,697D
Common stockF1,F4,F3May 25, 2017S509$46.92D90,737ISee footnote
Common stockF5holding———25,000ISee footnote
Common stockF6holding———25,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses